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Abstract Recently, the existence and extended diversity of
antimicrobial peptides has been revealed in two mussel species.
These molecules are classified into four groups according to
common features of their primary structure: defensins, mytilins,
myticins and mytimycin. In Mytilus galloprovincialis, gene
structure reveals synthesis as precursors in circulating hemo-
cytes. Synthesised even in absence of challenge, the precursors
mature and the peptides are stored in granules as active forms.
The different peptides are engaged in the destruction of bacteria
inside phagocytes, before being released into hemolymph to
participate in systemic responses. Such involvement in anti-
infectious responses is unique, and apparently more related to
those of mammalian phagocytes than to those of insects. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Even if suspected in the 1920s [1], invertebrate humoral
immunity was totally absent from records until the early
1980s when the Swedish group of Hans Boman began describ-
ing antibacterial proteins and peptides in insects [2]. Now,
more than 100 peptides have been puri¢ed from plants [3],
invertebrates [4,5] and vertebrates [6], and these peptides ap-
pear to be one of the actors in innate immunity that have been
conserved during evolution. Meanwhile, their involvements in
anti-infectious processes are di¡erent according to species,
cells and tissues. Many antimicrobial peptides are located in
epithelia, either of plants, insects or mammals [7], where they
prevent invasion by pathogens. Others may be especially
abundant in circulating cells. In horseshoe crabs, the peptides
are stored in hemocyte granules and released into the plasma
upon stimulation by microbial substances, such are lipopoly-
saccharides and L-glucans [4,8]. In contrast, mammalian pep-
tides accumulate in granulocytes and certain macrophages in
order to exert their microbicidal activity on engulfed bacteria
[9]. In insects, septic injury results in a rapid synthesis of
antimicrobial peptides, principally in the fat body, which are
released immediately into hemolymph where they participate
in a systemic response [10].
Extensively studied in arthropods, antimicrobial peptides
appeared as one of the components of antimicrobial host
defence throughout evolution. Meanwhile, until recently,
these peptides were unknown in other invertebrate phyla. Ap-
plying the same methodology used for isolating antimicrobial
peptides from insects, several small, cationic, cysteine-rich
peptides have been characterised from hemolymph of mussels,
a bivalve mollusc.
2. Diversity and structural features of mussel peptides
These small cationic antimicrobial peptides are character-
ised by their high cysteine content and they have been organ-
ised into four groups according to shared features of their
primary structure, mainly their consensus cysteine array
(Fig. 1). The ¢rst group comprises the defensins, which
show similarities with molecules of the arthropod defensin
family [5]. Two defensins containing six cysteines have been
characterised from the plasma of the blue mussel, Mytilus
edulis [11] and a defensin-like peptide, named MGD1 for My-
tilus galloprovincialis defensin-1, from the plasma and hemo-
cytes of the Mediterranean mussel, M. galloprovincialis
[12,13]. A second isoform, MGD2, has been isolated from a
hemocyte cDNA library [13]. MGDs are original members of
the arthropod defensin family because of the presence of two
extra cysteines, eight instead of six. As determined by 1H-
nuclear magnetic resonance [14], MGD1 three-dimensional
(3D) solution structure appeared highly constrained and con-
sists mainly of the canonical CSKL structural motif (Cys4^
Cys25, Cys10^Cys33 and Cys14^Cys35 disul¢de bonds) sim-
ilar to that of arthropod defensins [15], the two extra cysteines
(Cys21^Cys38) being engaged in an original fourth disul¢de
bond. Synthetic MGD1, correctly folded to form the four
disul¢de bonds, retains the antibacterial activity of native
MGD1, suggesting that the hydroxylation of Trp28 observed
in native MGD1 is not involved in the biological e¡ect. The
second group of molecules, the mytilins, consists of ¢ve iso-
forms (A, B, C, D and G1). Isoforms A and B were isolated
from M. edulis plasma [11], and isoforms B, C, D and G1
from M. galloprovincialis hemocytes [16]. The third group of
peptides includes the myticins A and B, that have been de-
rived and characterised from hemocytes (isoforms A and B)
and plasma (isoform A) of M. galloprovincialis [17]. Even if
possessing a similar molecular weight and eight cysteines, my-
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tilins and myticins are not related to any known molecule. In
addition, an anti-fungal peptide of 6.5 kDa containing 12
cysteines, mytimycin, has been partially characterised from
M. edulis plasma [11].
Our data revealed that mussel antimicrobial peptides are
produced in hemocytes and stored in hemocyte granules
[13,16,17]. cDNAs were isolated from hemocyte mRNAs
and revealed that defensins, mytilins and myticins are synthe-
sised as 81, 103 and 96 amino acid precursors, respectively
[13,16,17]. Consequently, the peptides are processed from pre-
cursors to active peptides within the hemocytes, an observa-
tion similar to that done in the Japanese horseshoe crab,
Tachypleus tridentatus [18], and in the shrimp, Penaeus vanna-
mei [19].
cDNAs of MGD1 and 2, mytilin B and myticins A and B
revealed that all initial translation products share the same
structural features with: (i) an N-terminal canonical signal
peptide, followed by (ii) the sequence corresponding to the
mature peptide and (iii) a C-terminal extension rich in anionic
residues. While the N-terminal pre-segment is presumed to be
a signal sequence for translocation to the lumen of the rough
endoplasmic reticulum, the functional signi¢cance of the C-
terminal extension is unknown. This region might interact
with the active peptide: (i) to neutralise positive charges of
the peptide, allowing suitable proteolytic processing and/or
addressing to a particular hemocyte compartment, or (ii) to
protect the producing cells from eventual cytotoxic e¡ects.
Similar C-terminal extension has been observed in other anti-
microbial peptide precursors, like the tachyplesin precursor
from T. tridentatus [18].
3. Biological activity of mussel peptides
Such a diversity of antimicrobial peptides is questionable.
One possible explanation results from establishment of an
activity spectrum of the di¡erent molecules [11,12,16,17]. De-
fensins and myticins are essentially active against Gram-pos-
itive bacteria, including some pathogens for marine inverte-
brates [20,21], and are much less active against Gram-negative
bacteria or fungi. Mytimycin is strictly anti-fungal. Mytilins
display a wider spectrum of activity according to isoforms.
Whereas B, C and D isoforms are toxic for both Gram-pos-
itive and Gram-negative bacteria, mytilin G1 displays activ-
ities only on Gram-positive bacteria. Mytilin B and C iso-
forms share a high degree of homology in their primary
structure. However, they possess di¡erent activities, especially
against the fungus Fusarium oxysporum, pathogen for marine
crustaceans [22,23], and against the Gram-negative bacteria
Fig. 1. Diversity of the mussel antimicrobial peptide families: defensins (A), mytilins (B), myticins (C) and mytimycin (D). Cysteines are boxed
revealing the consensus cysteine arrays. The two extra cysteines of MGDs are in red.
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Vibrio splendidus, pathogen for bivalve molluscs [24]. In fact,
the di¡erent peptide families and isoforms possess comple-
mentary properties that might permit an increase in antimi-
crobial capabilities of mussels.
All peptides exert bactericidal e¡ects, but important di¡er-
ences in kinetics have been observed. When the di¡erent pep-
tides were incubated with M. luteus, more than 2 and 6 h were
necessary for mytilin D and myticin A or mytilin G1, respec-
tively, to kill all bacteria, whereas only a few minutes in the
presence of either mytilins A, B, C or MGD1 were su⁄cient.
Such a rapid bactericidal activity resembles the action of de-
fensins from the £esh£y, Phormia terranovae. In this insect,
defensins disrupt within seconds the permeability barrier of
the cytoplasmic membrane of Gram-positive bacteria, result-
ing in partial depolarisation, decrease in cytoplasmic ATP,
inhibition of respiration and rapidly ensuing death [25] per-
haps by apoptosis.
4. Location and ontogeny of expression
Hemocytes are the main site for precursor production of
defensins, mytilins and myticins, as con¢rmed by Northern
blot analysis. Nevertheless, among mussel tissues, mantle, la-
bial palps, gills and digestive gland showed a faint band with
the same mobility as that of hemocytes [13,16,17]. In fact,
these bands are probably derived from insigni¢cant numbers
of contaminant hemocytes in the dissected tissues as demon-
strated by in situ hybridisation. Indeed, numerous hemocytes
expressing these genes were found throughout mussel body,
both in sinuses or in¢ltrating tissues, particularly in epithelia
in contact with the environment [26]. Moreover, in situ hy-
bridisation revealed a di¡erential distribution of hemocytes
expressing these di¡erent genes. Whereas numerous defensin-
expressing cells were shown to in¢ltrate the digestive tubule
epithelia, mytilin- and myticin-expressing cells are much less
or not represented in these epithelia, respectively. In addition,
mytilin- and myticin-expressing cells are well represented in
gills, where no defensin positive cells were observed. These
data suggest that: (i) di¡erent genes are expressed in di¡erent
hemocyte sub-types and (ii) di¡erent peptides are transported
by their respective expressing hemocytes to di¡erent areas of
the mussel. Consequently, and in addition to the increase of
antimicrobial capabilities (isoforms with complementary anti-
microbial properties), another biological signi¢cance of the
peptide diversity could result from their involvement in di¡er-
ent regions of the mussel body.
Fig. 2. Confocal microscopy imaging of defensins (green) and mytilins (red) double immune labelling in mussel hemocytes. Hemocytes were
¢xed, centrifuged onto slides and subjected to immune histochemical detection of defensins (A, D) and mytilins (B, E) using FITC-labelled and
Texas red-labelled secondary antibody, respectively. C, F are the merged confocal images of A and B and D and E, respectively. Defensin im-
mune reactivity was detected as small intensely £uorescent particles distributed throughout the cytoplasm (A and D). Mytilin immune reactivity
was also detected throughout the cytoplasm, the labelling being more intense at the cell periphery (B and E). Hemocytes might be positive ei-
ther for defensins (green arrow) or for mytilins (red arrow) but both immune reactivities often appeared within the same cells. Merged confocal
microscope images suggested that defensins and mytilins were packed in di¡erent (blue arrow) or in the same (yellow arrow) cell compartments.
Note that some hemocytes did not stain positively for defensins or for mytilins (C, white arrow). Scale bar: 25 Wm.
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In addition, we demonstrated the presence of mytilin B
messenger and peptide in enterocytes [26]. In a previous study,
we reported the presence of defensin-like molecules in the
intestinal epithelium and their location in granular structures
contained in enterocytes [13]. Similar location of antimicrobial
peptides expression in epithelial cells of gastrointestinal tracts
has been reported in insects [27,28] and mammals, where they
were observed in Paneth cells [29]. Our data suggested that a
similar mechanism of local mucosal defence against microor-
ganisms also exists in mussel intestine.
Knowledge of immune ontogeny is of particular importance
as bivalve larvae are susceptible to bacterial infections, espe-
cially by marine Vibrios, which are pathogenic for larval
stages in several bivalve molluscs, including mussels [30].
Although phagocytic cells and certain enzymes associated
with adult hemocytes are present in larval mussels and oysters
[31], bivalve larvae are not fully competent to ¢ght infections.
In previous studies, we demonstrated that most of the mytilins
are active against marine Vibrios [16]. Consequently, larval
susceptibility to Vibrios could be linked to the lack of expres-
sion of particular antimicrobial peptides in early developmen-
tal stages. Indeed, mRNAs encoded by mytilin B and MGD2
genes were undetectable from eggs to settlement, the expres-
sion of both genes starting during (mytilin B) or 1 week after
(MGD2) metamorphosis [32]. During metamorphosis, drastic
morphological changes occurred in molluscs, during which
larval organs disappeared and relative sizes of permanent or-
gans and their orientation were changed [33]. Our results sug-
gested that the maturation of immune functions also occurred
during metamorphosis.
5. Localisation of defensins and mytilins in hemocytes
Even if both stored in granulocytes, defensins and mytilins
are observed in di¡erent subcellular organelles. As revealed by
ultrastructural immunocytochemistry, defensins are located:
(i) in vesicles of granulocytes containing small granules, and
(ii) in large granules of granulocytes containing large granules
[13]. Using the same techniques, mytilin labelling was exclu-
sively observed in granulocytes exhibiting large granules and
particularly in the large multivesicular structures [16]. Conse-
quently, defensins and mytilins seemed to be partially distrib-
Fig. 3. Dual localisation of peptides and phagocytosed bacteria. Hemocytes were incubated for 20 min in the presence of FITC-labelled Vibrio
alginolyticus, then ¢xed and subjected to immune cytochemical detection of mytilins using a Texas red-labelled secondary antibody. Analysis by
confocal microscopy showed that mytilin-containing hemocytes were capable of phagocytosis (B, green arrow). Furthermore, in numerous cases,
mytilin immune reactivity was co-localised with bacteria in cellular organelles (A and B, yellow arrow). Scale bar: 10 Wm. (C and D) Hemo-
cytes were ¢rst incubated 20 min with bacteria and then submitted to the immune cytochemical detection of mytilins (C) and defensins (D) us-
ing a 15 nm gold particle-conjugated secondary antibody. After phagocytosis, the co-localisation of bacteria and mytilins appeared in phagoly-
sosomes (C). Exocytosis of some mytilin-containing granules into phagosomes suggested a probable fusion of the two organelles (C, arrow).
No defensin labelling was observed in phagocytosing cells (D). b, bacteria; n, nucleus; pl, phagolysosome. Scale bar = 1 Wm.
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uted in the same hemocyte sub-population. Using confocal
microscopy [26], we observed that 37% of hemocytes only
stained positively for mytilins and 16% only for defensins,
32% contained both reactivity among which 21% exhibit a
co-localisation in the same structures (Fig. 2). Finally, 15%
of the hemocytes were not labelled. Such a localisation of
both peptides within the same cells, packed in di¡erent or in
the same cell compartments, was con¢rmed by electron mi-
croscopy observations [26].
6. Gene organisation
Three defensin cDNAs, sharing a high degree of homology,
have been described: (i) a cDNA fragment corresponding to
MGD1 obtained by reverse transcription-PCR, (i) the cDNA
corresponding to MGD2a obtained by screening a hemocyte
cDNA library, and (i) a cDNA fragment corresponding to
MGD2b obtained by 5P rapid ampli¢cation of cDNA ends-
PCR [32]. In addition, two di¡erent myticin cDNAs were
obtained by screening the hemocyte cDNA library [17]. Since
these di¡erent cDNAs were obtained from mRNA prepared
from hemocytes of numerous mussels, it was not clear
whether the isoforms are expressed in the same mussel. South-
ern blot analysis suggested that defensin and myticin genes are
present as a single copy in the genome [17,32]. Consequently,
di¡erences in cDNA sequences probably resulted from genetic
polymorphism. For mytilin B gene, Southern blot analysis
suggested that at least two genes exist in the genome [32],
probably encoding mytilin B and one of the numerous mytilin
isoforms.
MGD2b and mytilin B genes have been cloned and se-
quenced, revealing that they both contain three large introns
representing 83 and 75% of the nucleotides, respectively [32].
Moreover, the two genes are organised similarly and exons
encode precursor domains that ful¢l di¡erent functions. The
second intron of both genes contains the cDNA sequence
encoding the signal sequence required to address the precursor
to the lumen of the endoplasmic reticulum, and the third and
largest exon contains, in both genes, the sequence encoding
the mature peptide. According to this particular structure, we
hypothesised that the di¡erent domains of pre-existing genes
could have been combined (by recombination) to create new
genes able to ful¢l new functions.
7. Involvement in defence
Subjecting mussels to bacterial challenge approached the
participation of antimicrobial peptides in anti-infectious pro-
cesses. Defensins and mytilin B messenger concentrations in
circulating hemocytes did not increase after bacterial chal-
lenge [32], but mytilin-containing hemocytes migrated and ac-
cumulated around infectious sites in the ¢rst hours following
bacteria injection [16]. This argued in favour of a local par-
ticipation of mytilins in antimicrobial responses. Meanwhile,
the local participation of mytilins can be: (i) extracellular after
exocytosis of peptides into the immediate hemocyte environ-
ment or (ii) intracellular after engulfment of bacteria. To dis-
tinguish between these two possibilities, hemocytes were con-
fronted with bacteria in vitro. Observations on both confocal
and electron microscopy revealed that: (i) mytilin-containing
granulocytes were able to phagocytose bacteria, (ii) engulfed
bacteria are ¢rst localised in phagosome-like structures and
then (iii) bacteria and mytilins co-localised in phagolyso-
some-like organelles (Fig. 3). Moreover, exocytosis of myti-
lin-containing granules into phagosomes was observed sug-
gesting that the co-localisation of bacteria and mytilins
occurred after fusion of phagosomes with mytilin-containing
granules [26].
As defensin immune reactivity was never detected in phag-
ocytic cells (Fig. 3), the granulocyte sub-type containing only
mytilins seems to be the only one involved in phagocytosis of
bacteria. Furthermore, confocal microscopy observations
demonstrated that a sub-population of circulating hemocytes
contained both defensins and mytilins [26]. The role of this
latter hemocyte sub-type remains to be elucidated. Bacterial
challenge triggered an increase of plasma-associated defensin
and mytilin concentrations 24 h later and provided evidences
for hemocyte origin of the released peptides, i.e. exocytosis
¢gures of mytilin-containing granules and shifting of defensin
immune reactivity towards the plasma membrane [13,16]. The
granulocyte sub-type containing both peptides could be in-
volved in these simultaneous plasmatic increases. Co-localisa-
tion of defensins and mytilins in the same granules, revealed
by both confocal and electron microscopy, supports the hy-
pothesis that both peptides are simultaneously released by
exocytosis. Consequently, we hypothesised that the two gran-
ulocyte sub-types, one containing only mytilins and the other
containing both defensins and mytilins, are probably involved
at di¡erent stages of the anti-infectious response. The ¢rst
sub-type would be involved in an early phase response by
migrating towards infectious sites and phagocytosing micro-
organisms and the second sub-type would be involved at a
later stage by releasing the peptides that trigger systemic re-
sponse.
8. An original model
Consequently, we propose that the involvement of antimi-
crobial peptides in mussels constitutes an original model of
anti-infectious defence in invertebrates based on: (i) molecular
structures (cysteine array and 3D) similar to that of insect
defensins, (ii) constitutive expression in circulating hemocytes
and storage in di¡erent granules of di¡erent hemocytes, and
(iii) two routes of involvement, immediate intracellular and
later as released in plasma. In contrast, a di¡erent system
operates in insects, where the expression of antimicrobial pep-
tide encoding genes is undetectable in non-challenged animals
but immediately triggered by bacterial injection, showing sim-
ilarities with that of the mammalian acute phase response
genes [34]. The horseshoe crab model is also di¡erent, even
if hemocytes also produce and store antimicrobial peptides in
hemocyte granular organelles. In this case, upon stimulation
by microbial substances, such as lipopolysaccharides and L-
glucans, hemocytes degranulate and release into the immedi-
ate cell environment a series of substances involved in immune
defence, including antimicrobial peptides [4]. Even if sharing
the same name, human defensins possess totally di¡erent ami-
no acid sequences and molecular structures. In fact, the mus-
sel model exhibits functional similarities with that reported for
human neutrophil K-defensin peptides (HNP), in which
HNP1^4 are stored in azurophil granules that discharge their
contents into microbe-containing phagosomes through a pro-
cess of phagosome^granule fusion [35]. HNP do not appear to
be massively secreted. Meanwhile, increased plasma levels of
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human defensins have been reported in patients with septicae-
mia or bacterial meningitis [36] arguing in favour of a putative
systemic antimicrobial response of these peptides, as observed
in mussels.
Recent data have highlighted similarities between pathogen
recognition and signalling pathways of innate immunity in
arthropods and mammals [37]. Here, we describe a new inver-
tebrate model of antimicrobial peptide involvement in mollusc
that is closely related to that of mammals, but mediated by
molecules structurally related to those of insects. Our present
knowledge accumulated from di¡erent phyla suggests that
vertebrate innate immunity is a patchwork of ancestral mech-
anisms still present in more primitive animals.
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